Genetic Method for Evaluating Solubility of Recombinant Proteins in E. coli

Information

  • Research Project
  • 7272222
  • ApplicationId
    7272222
  • Core Project Number
    R43GM080830
  • Full Project Number
    1R43GM080830-01
  • Serial Number
    80830
  • FOA Number
    PA-06-20
  • Sub Project Id
  • Project Start Date
    5/1/2007 - 17 years ago
  • Project End Date
    10/31/2008 - 16 years ago
  • Program Officer Name
    PORTNOY, MATTHEW
  • Budget Start Date
    5/1/2007 - 17 years ago
  • Budget End Date
    10/31/2008 - 16 years ago
  • Fiscal Year
    2007
  • Support Year
    1
  • Suffix
  • Award Notice Date
    4/23/2007 - 17 years ago

Genetic Method for Evaluating Solubility of Recombinant Proteins in E. coli

[unreadable] DESCRIPTION (provided by applicant): For most applications, recombinant proteins must be purified in soluble form; however, when expressed in E. coli, many proteins fold aberrantly and become an insoluble aggregate in the cell. We propose to create a genetic method to allow scientists using E. coli for recombinant protein expression to immediately ascertain whether their target is soluble or insoluble. This is done directly without having to grow cultures of these cells and isolate protein. In addition, this method would also comprise a genetic selection for identifying domains or mutants of insoluble proteins that are soluble, making them amenable to downstream applications. 7. PROJECT NARRATIVE A central component towards the understanding of human, animal, and all cell biology is the study of the proteins encoded by the organism. We propose to develop a novel method to accelerate the study of proteins by creating a rapid way to evaluate whether the protein of interest can be immediately purified and studied or whether it needs to be modified before this work can begin. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    114758
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:114758\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GENE THERAPY SYSTEMS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92121
  • Organization District
    UNITED STATES